166 related articles for article (PubMed ID: 3034596)
1. Single amino acid changes that render human IFN-alpha 2 biologically active on mouse cells.
Weber H; Valenzuela D; Lujber G; Gubler M; Weissmann C
EMBO J; 1987 Mar; 6(3):591-8. PubMed ID: 3034596
[TBL] [Abstract][Full Text] [Related]
2. Structure-function analysis of mouse interferon alpha species: MuIFN-alpha 10, a subspecies with low antiviral activity.
Trapman J; van Heuvel M; de Jonge P; Bosveld IJ; Klaassen P; Zwarthoff EC
J Gen Virol; 1988 Jan; 69 ( Pt 1)():67-75. PubMed ID: 2826671
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antiviral activity, and conformational characterization of mouse-human alpha-interferon hybrids.
Raj NB; Israeli R; Kelley KA; Leach SJ; Minasian E; Sikaris K; Parry DA; Pitha PM
J Biol Chem; 1988 Jun; 263(18):8943-52. PubMed ID: 2837469
[TBL] [Abstract][Full Text] [Related]
4. Extracellular production of mouse interferon beta by the Bacillus subtilis alpha-amylase secretion vectors: antiviral activity and deduced NH2-terminal amino acid sequences of the secreted proteins.
Nakazawa K; Sasamoto H; Shiraki Y; Harada S; Yanagi K; Yamane K
Intervirology; 1991; 32(4):216-27. PubMed ID: 1650763
[TBL] [Abstract][Full Text] [Related]
5. A recombinant human interferon-alpha B/D hybrid with a broad host-range.
Horisberger MA; de Staritzky K
J Gen Virol; 1987 Mar; 68 ( Pt 3)():945-8. PubMed ID: 3029315
[TBL] [Abstract][Full Text] [Related]
6. Carboxyterminal region of hybrid leukocyte interferons affects antiviral specificity.
Franke AE; Shepard HM; Houck CM; Leung DW; Goeddel DV; Lawn RM
DNA; 1982; 1(3):223-30. PubMed ID: 6301784
[TBL] [Abstract][Full Text] [Related]
7. Site-specific mutagenesis of the human fibroblast interferon gene.
Mark DF; Lu SD; Creasey AA; Yamamoto R; Lin LS
Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5662-6. PubMed ID: 6091102
[TBL] [Abstract][Full Text] [Related]
8. Virus-specific effects of recombinant porcine interferon-gamma and the induction of Mx proteins in pig cells.
Horisberger MA
J Interferon Res; 1992 Dec; 12(6):439-44. PubMed ID: 1337754
[TBL] [Abstract][Full Text] [Related]
9. Creation of interferon-alpha8 mutants with amino acid substitutions against interferon-alpha receptor-2 binding sites using phage display system and evaluation of their biologic properties.
Yamamoto K; Taniai M; Torigoe K; Yamamoto S; Arai N; Suemoto Y; Yoshida K; Okura T; Mori T; Fujioka N; Tanimoto T; Miyata M; Ariyasu H; Ushio C; Fujii M; Ariyasu T; Ikeda M; Ohta T; Kurimoto M; Fukuda S
J Interferon Cytokine Res; 2009 Mar; 29(3):161-70. PubMed ID: 19196068
[TBL] [Abstract][Full Text] [Related]
10. Two domains in alpha interferons influence the efficacy of the antiviral response.
Zwarthoff EC; Gennissen A; Bosveld IJ; Trapman J; van Heuvel M
Biochem Biophys Res Commun; 1987 Aug; 147(1):47-55. PubMed ID: 2820400
[TBL] [Abstract][Full Text] [Related]
11. Properties of natural and hybrid murine alpha interferons.
Van Heuvel M; Bosveld IJ; Mooren AA; Trapman J; Zwarthoff EC
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2215-22. PubMed ID: 3020159
[TBL] [Abstract][Full Text] [Related]
12. Single amino acid substitutions at conserved residues of human interferon-alpha can effect antiviral specific activity.
Nisbet IT; Beilharz MW; Hertzog PJ; Tymms MJ; Linnane AW
Biochem Int; 1985 Sep; 11(3):301-9. PubMed ID: 3904757
[TBL] [Abstract][Full Text] [Related]
13. Effect of amino acids on the expression of antiviral activity of different types of human interferon. I. Effect of single amino acids.
Tóth S; Mécs I
Acta Microbiol Hung; 1985; 32(4):363-8. PubMed ID: 3012929
[TBL] [Abstract][Full Text] [Related]
14. The cross-species antiviral activities of different IFN-tau subtypes on bovine, murine, and human cells: contradictory evidence for therapeutic potential.
Alexenko AP; Ealy AD; Roberts RM
J Interferon Cytokine Res; 1999 Dec; 19(12):1335-41. PubMed ID: 10638702
[TBL] [Abstract][Full Text] [Related]
15. Biological activities of synthetic peptides of the sequence of human interferon-alpha.
Eichmann E; Majarov VA; Kozhich AT; Noll F; Zav'yalov VP
Immunol Lett; 1990 Jul; 24(4):233-6. PubMed ID: 2167875
[TBL] [Abstract][Full Text] [Related]
16. Control of the interferon system: an inhibitor of interferon action.
Lefkowitz EJ; Fleischmann WR
Tex Rep Biol Med; 1981-1982; 41():317-23. PubMed ID: 6294894
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of interferon action. Interferon alpha inhibits vesicular stomatitis virus primary transcript accumulation in P1/eIF-2 alpha protein kinase-deficient human fibroblast cells.
Zhang XT; Samuel CE
J Biol Regul Homeost Agents; 1987; 1(4):157-65. PubMed ID: 2845723
[TBL] [Abstract][Full Text] [Related]
18. Antiviral and protein-inducing activities of recombinant human leukocyte interferons and their hybrids.
Sen GC; Herz R; Davatelis V; Pestka S
J Virol; 1984 May; 50(2):445-50. PubMed ID: 6200607
[TBL] [Abstract][Full Text] [Related]
19. Specific residues within an amino-terminal domain of 35 residues of interferon alpha are responsible for recognition of the human interferon alpha cell receptor and for triggering biological effects.
Shafferman A; Velan B; Cohen S; Leitner M; Grosfeld H
J Biol Chem; 1987 May; 262(13):6227-37. PubMed ID: 2952649
[TBL] [Abstract][Full Text] [Related]
20. Structure-function analysis of murine interferon-alpha: antiviral properties of novel hybrid interferons.
Van Heuvel M; Bosveld IJ; Klaassen P; Zwarthoff EC; Trapman J
J Interferon Res; 1988 Feb; 8(1):5-14. PubMed ID: 3367062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
